Since 2018, NCD 90.2 has controlled applications of NGS in Medicare cancer patients. At regular intervals, CMS updates the claims processing instructions. Some updates are released in CR13939, June 25, 2025.
https://www.cms.gov/files/document/r13286otn.pdf
- Delete 0448U Oncoreveal, Lung and Colon Cancer, 12/31/2024.
- Add 0523U Oncoreveal CDx, 1/1/2025.
- Add TruSight Comprehensive, 0543U, 4/1/2025.
- Add MI Cancer Seek [caris] 0211U, 11/5/2024 [FDA approval]
See additional Excel tables,
Generally, an even-quarter date reflects when a code became effective. As above, an odd calendar date usually reflects when FDA approval becomes effective. Effective dates may be 3-9 months prior to the CMS publication of them.
